Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats.
A 2-year inhalation study was conducted in Sprague-Dawley rats with 1,3-butadiene. Groups of 110 male and 110 female rats inhaled 1,3-butadiene at 0, 1000, or 8000 ppm for 6hr/day, 5 days/week. Interim clinical pathology, neuromuscular, and histopathology investigations were carried out. The study terminated at 20 to 25% survival (105 weeks for females, 111 weeks for males). Following exposure to 1,3-butadiene there were no effects on hematology, blood chemistry, urine analysis, and neuromuscular function that definitely could be associated with treatment. Treatment was associated with changes in clinical condition, suppression of body weight gain, reduced survival, and increases in certain organ weights and in both common and uncommon tumor types. Although the biological interpretation of the significance of some of the tumor types is equivocal, the evidence suggests that the test article is an oncogen to the rat under the conditions of exposure used in this study, and the mechanism is more likely to be an indirect effect through the endocrine system, rather than a direct effect through the production of reactive metabolites.
Owen
P E
PE
Life Science Research, Eye, Suffolk, UK.
Glaister
J R
JR
D000395:Air Pollutants, Occupational / Q000633:toxicity*; D000818:Animals; D002070:Butadienes / Q000008:administration & dosage / Q000633:toxicity*; D002273:Carcinogens; D005260:Female; D007668:Kidney / Q000187:drug effects; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009469:Neuromuscular Junction / Q000187:drug effects; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains
D000395:Air Pollutants, Occupational; D002070:Butadienes; D002273:Carcinogens; C031763:1,3-butadiene